Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. (Q52014753)

19 April 2018

title

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. (English)

1 reference

19 April 2018

author name string

H W Eichstädt

1

1 reference

19 April 2018

H Eskötter

2

1 reference

19 April 2018

I Hoffman

3

1 reference

19 April 2018

H W Amthauer

4

1 reference

19 April 2018

G Weidinger

5

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 July 1995

1 reference

19 April 2018

American Journal of Cardiology

published in

1 reference

19 April 2018

volume

76

1 reference

19 April 2018

issue

2

1 reference

19 April 2018

page(s)

122A-125A

1 reference

19 April 2018

The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

Is endothelial dysfunction reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980033-5

10.1016/S0002-9149(05)80033-5

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

7604786

1 reference

19 April 2018